Bio Roundup: Biotech IPOs, Migraine Progress, Takeda Woos Shire & More
Xconomy
MARCH 30, 2018
in the first quarter was up 44 percent compared to the same period a year ago, according to data compiled by consulting and accounting firm EY. If the recent IPO activity seems to be on overdrive, it’s not your imagination. The number of companies filing to go public in the U.S.
52 
Let's personalize your content